1. Patient info
2. » Active substances
3. » Medicines containing active substance autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous CD54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor ()

Medicines containing active substance autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous CD54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor ()

• Provenge Patient leaflet Summary of medicine characteristics